Search | IOVS | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Expandable and Cryopreservable Retinal Progenitors: A new cell tool

Sacha Reichman; Vivien Batoumeni; Tara Fournier; Céline Nanteau; Anais Potey; marilou clemencon; Gael Orieux; Jose Sahel; Olivier Goureau; Jerome E Roger; Sandy Gozlan

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3850.

ARVO Annual Meeting Abstract June 2023

Photoreceptors participate in the development of the deep vascular plexus through O tx2 / Crx gene regulatory network.

Jerome E Roger; Elodie-Kim Grellier; Sophie Lourdel; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3628.

ARVO Annual Meeting Abstract June 2022

AAV-mediated hPDE6B gene therapy preserves retinal function in rd10 mice

Gaelle M Lefevre; Nicole Brument; Elodie-Kim Grellier; Jerome E Roger; nicolas ferry

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):68 – A0041.

ARVO Annual Meeting Abstract June 2022

Osteopontin might mediate photoreceptor neuroprotection following GSK3 inhibition

Catherine Hottin; Sophie Lourdel; Muriel Perron; Jerome E Roger

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2972 – F0213.

ARVO Annual Meeting Abstract June 2022

Efficacy of CRX gene therapy for treating mouse models of dominant CRX -associated retinopathies and beyond.

Jerome E Roger; Elodie-Kim Grellier; Sophie Lourdel; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3471.

ARVO Annual Meeting Abstract June 2021

YAP protects the eye from uveitic glaucoma by preserving retinal and anterior chamber homeostases

Juliette Bitard; Elodie-Kim Grellier; Sophie Lourdel; Helena Filipe; Annaig Hamon; Francois Fenaille; Florence Castelli; Emeline Chu-Van; Jerome E. Roger; Morgane Locker; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2356.

ARVO Annual Meeting Abstract June 2021

CRX gene therapy targeting mouse models of dominant CRX-associated retinopathies.

Jerome E Roger; Elodie-Kim Grellier; Sophie Lourdel; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1180.

ARVO Annual Meeting Abstract June 2020

Universal Responses to Stress in Inherited Retinal Degeneration

John D Ash; Jerome E Roger; Elodie-Kim Grellier; Anand Swaroop; Katya Lobanova; Casey Keuthan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3221.

ARVO Annual Meeting Abstract July 2019

Identification of new survival pathways activated by neurotrophic factors using whole transcriptome analysis of flow-sorted photoreceptors.

Jerome E Roger; Elodie-Kim Grellier; Linn Gieser; Anand Swaroop; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4886.

ARVO Annual Meeting Abstract July 2019

Secondary cone degeneration is prevented by HDAC inhibition

Dragana Trifunovic; Klaudija Masarini; Angela Armento; Jerome E. Roger; Marius Ueffing

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5180.

ARVO Annual Meeting Abstract July 2018

Regional Changes of the Retinal Transcriptome in Humans: Diabetes or Retinopathy signature?

Patrice E Fort; Yang Shan; Jerome E Roger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1208.

ARVO Annual Meeting Abstract July 2018

Glycogen Synthase Kinase 3 restrain the genesis of displaced ganglion cells during retinal development.

Jerome E Roger; Elena Braginskaja; Leah Thomas; Anand Swaroop; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2595.

ARVO Annual Meeting Abstract June 2017

Glycogen Synthase Kinases 3 control photoreceptor development and homeostasis by modulating NRL stability

Elena Braginskaja; Jessica Gumerson; Muriel Perron; Anand Swaroop; Jerome E Roger

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):348.

ARVO Annual Meeting Abstract June 2017

Photoreceptor expression of functional Crx is required to maintain retinal pigment epithelium and retinal vasculature integrity.

Jerome E Roger; Elodie-Kim Grellier; Nareh Sahakian; Muriel Perron

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5372.

Retinal Cell Biology April 2017

Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells

PDF

Annaïg Hamon; Christel Masson; Juliette Bitard; Linn Gieser; Jérôme E. Roger; Muriel Perron
TAGS: retina, retinal degeneration, rna, photoreceptors, precipitating factors, mice, proteins, western blotting, immunohistochemistry
Invest. Ophthalmol. Vis. Sci.. 2017; 58(4):1941-1953. https://doi.org/10.1167/iovs.16-21366

Includes: Supplemental Content

ARVO Annual Meeting Abstract September 2016

Requirement for Microglia for the Maintenance of Synaptic Function and Integrity in the Mature Retina

Xu Wang; Lian Zhao; Jun Zhang; Robert N Fariss; Wenxin Ma; Friedrich Kretschmer; Minhua Wang; Haohua Qian; Tudor C Badea; Jerome E Roger; Wai T Wong

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Whole transcriptome sequencing in rd10 revealed new factors and pathways involved in stem cells biology and neuroprotection in the inner retina and ciliary body.

Jerome E Roger; Linn Gieser; Megan Barnes; Annaïg HAMON; christel Masson-Garcia; Muriel PERRON

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3194.

ARVO Annual Meeting Abstract September 2016

Retinal degeneration triggers the activation of the Hippo pathway effector gene YAP in reactive Müller cells

christel Masson-Garcia; Annaïg HAMON; Juliette Bitard; Jerome E Roger; Muriel PERRON

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4201.

ARVO Annual Meeting Abstract September 2016

Müller cell-derived YAP signaling as a new neuroprotective pathway in the degenerating retina

Annaïg HAMON; Jerome E Roger; Juliette Bitard; christel Masson-Garcia; Elodie Grellier; Muriel PERRON

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4202.

ARVO Annual Meeting Abstract June 2015

Hippo pathway in Muller glia cell during retinal degeneration

Juliette Bitard; Annaïg Hamon; Christel Masson; Jerome E Roger; Muriel PERRON

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):416.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Expandable and Cryopreservable Retinal Progenitors: A new cell tool

Photoreceptors participate in the development of the deep vascular plexus through O tx2 / Crx gene regulatory network.

AAV-mediated hPDE6B gene therapy preserves retinal function in rd10 mice

Osteopontin might mediate photoreceptor neuroprotection following GSK3 inhibition

Efficacy of CRX gene therapy for treating mouse models of dominant CRX -associated retinopathies and beyond.

YAP protects the eye from uveitic glaucoma by preserving retinal and anterior chamber homeostases

CRX gene therapy targeting mouse models of dominant CRX-associated retinopathies.

Universal Responses to Stress in Inherited Retinal Degeneration

Identification of new survival pathways activated by neurotrophic factors using whole transcriptome analysis of flow-sorted photoreceptors.

Secondary cone degeneration is prevented by HDAC inhibition

Regional Changes of the Retinal Transcriptome in Humans: Diabetes or Retinopathy signature?

Glycogen Synthase Kinase 3 restrain the genesis of displaced ganglion cells during retinal development.

Glycogen Synthase Kinases 3 control photoreceptor development and homeostasis by modulating NRL stability

Photoreceptor expression of functional Crx is required to maintain retinal pigment epithelium and retinal vasculature integrity.

Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells

Requirement for Microglia for the Maintenance of Synaptic Function and Integrity in the Mature Retina

Whole transcriptome sequencing in rd10 revealed new factors and pathways involved in stem cells biology and neuroprotection in the inner retina and ciliary body.

Retinal degeneration triggers the activation of the Hippo pathway effector gene YAP in reactive Müller cells

Müller cell-derived YAP signaling as a new neuroprotective pathway in the degenerating retina

Hippo pathway in Muller glia cell during retinal degeneration

To View More...

You must be signed into an individual account to use this feature.